CEB3: Cost-Effectiveness of Prevention of Coronary Heart Disease (CHD) with Simvastatin in Poland (Englisch)
- Neue Suche nach: Kuzniar, J.
- Neue Suche nach: Orlewska, E.
- Neue Suche nach: Hermanowski, T.
- Neue Suche nach: Romandzuk, W.
- Neue Suche nach: Splawinski, J.
- Neue Suche nach: Kuzniar, J.
- Neue Suche nach: Orlewska, E.
- Neue Suche nach: Hermanowski, T.
- Neue Suche nach: Romandzuk, W.
- Neue Suche nach: Splawinski, J.
In:
VALUE IN HEALTH
;
3
, 2
;
59
;
2000
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:CEB3: Cost-Effectiveness of Prevention of Coronary Heart Disease (CHD) with Simvastatin in Poland
-
Beteiligte:Kuzniar, J. ( Autor:in ) / Orlewska, E. ( Autor:in ) / Hermanowski, T. ( Autor:in ) / Romandzuk, W. ( Autor:in ) / Splawinski, J. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 3, 2 ; 59
-
Verlag:
- Neue Suche nach: VALUE IN HEALTH
-
Erscheinungsdatum:01.01.2000
-
Format / Umfang:59 pages
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 3, Ausgabe 2
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- 49
-
D1: Development and Validation of a Screening Instrument for Gastroesophageal Reflux DiseaseFullerton, S. / Emery, K. / Reyes, E. / Lee, J. / Shaw, M. / Shafiroff, J. / Willian, M. K. / Grogg, A. / Sadik, K. / Ofman, J. et al. | 2000
- 49
-
D3: A Pharmacoeconomic Model to Assess the Cost-Effectiveness of Trovafloxacin Compared to Ceftazidime for Nosocomial Pneumonia in a Public Hospital Setting in Hong KongLee, K. K. C. / You, J. H. S. / Ho, S. S. S. / Chan, T. Y. K. et al. | 2000
- 49
-
D2: Cost Utility of Docetaxel vs Vinorelbine or Paclitaxel in Advanced Breast CancerBrown, R. / Hutton, J. et al. | 2000
- 50
-
R1: Quantifying the Impact of Interactions Between HMG-COA Reductase Inhibitors (Stains) and Cytochrome P-450 Interacting Drugs on Healthcare Utilization: A Population-Based StudyIskedjian, M. / Metege, C. J. / Einarson, T. R. / Yogendran, M. / Mukherjee, J. et al. | 2000
- 50
-
D4: Economic Analysis of Warfarin in Outpatients with Atrial Fibrillation: Innovator Versus GenericMittman, N. / Bartle, W. / Walker, S. E. / Oh, P. I. et al. | 2000
- 51
-
R3: Donepezil Use and Impact on Cost Among Patients with Alzheimer's DiseaseWest, W. A. / Prashker, M. / Merriman, L. / Anderson, J. / Miller, D. et al. | 2000
- 51
-
R2: Risk Factors for Short-Term Diabetes Complications: An Analysis of Linked Administrative Claims and Clinical Laboratory DataMenzin, J. / Boulanger, L. / Friedman, M. / Langley-Hawthorne, C. / Cavanaugh, R. et al. | 2000
- 51
-
R4: Availability of Highly Active Antiretroviral Therapy Associated with Increased Survival and Lower Costs at a VA Medical CenterMcCollum, M. / Malone, D. C. / MacWhinney, S. / Bessesen, M. et al. | 2000
- 52
-
DH1: An Analysis of the Impact of Medication Non-Adherence and Type of Medication on Outcome Domains Using the SCAP Health QuestionnaireRusso, P. / Dirani, R. et al. | 2000
- 52
-
DH2: Medicare's Extended Immunosuppression Coverage Improved Middle-Income Renal Graft SurvivalWoodward, R. S. / Schnitzler, M. A. / Hollenbeak, C. S. / Lowell, J. A. / Singer, G. G. / Cohen, D. S. / Spitznagel, E. L. / Brennan, D. C. et al. | 2000
- 52
-
DH3: Public Report Spurs Hospital Mortality ReductionCzerwinski, A. A. / Horgan, M. M. et al. | 2000
- 53
-
Q1: Consumer and Staff Validation of a Self-Administered Health-Related Quality of Life Instrument for Individuals with SchizophreniaBarr, J. T. / Schumacher, G. E. / Mason, E. J. / Ohman, S. M. / Hanson, A. et al. | 2000
- 53
-
DH4: Schizophrenic Care and Assessment Program (SCAP): Impact of Clinical and Functional Status and Type of Medication Treatment on Outpatient Psychiatric UtilizationRusso, P. / Dirani, R. / Smith, M. et al. | 2000
- 54
-
Q2: Patient Preferences for Treatment Outcomes in Disabling TremorLeidy, N. K. / Palmer, C. / Coughlin, C. / Halpern, M. / Charles, D. et al. | 2000
- 54
-
Q3: Health-Related Quality of Life (HRQOL) in African American Men with Prostate Cancer: Data from CaPSURELubeck, D. P. / Grossfeld, G. / Ray, P. / Flanders, S. C. / Carroll, P. R. et al. | 2000
- 55
-
ICP2: The Relative Effectiveness of Selective Serotonin Reuptake Inhibitors (SSRIs) and Tricyclic Antidepressants (TCAs) in Reducing Worker AbsenteeismTreglia, M. / Neslusan, C. et al. | 2000
- 55
-
ICP1: Incorporating Measurement of Indirect Costs in the Evaluation of an Asthma Health Management ProgramErshoff, D. H. / Buchner, D. A. et al. | 2000
- 56
-
ICP4: Health State Preferences in Diabetic Peripheral NeuropathyDevine, E. B. / Sullivan, S. D. / Lew, D. P. / Veenstra, D. L. et al. | 2000
- 56
-
ICP3: Factors Influencing Patient Willingness to Pay for Diabetes Disease State Management ProgramsBarner, J. C. et al. | 2000
- 56
-
CAN1: Comparison of Cost of Asthma Treatment Between Patients Treated with Anti-Inflammatories Versus BronchodilatorsHuse, D. M. / Russell, M. W. / Weiss, S. T. / Hartz, S. C. et al. | 2000
- 57
-
CAN3: Baseline Cost of Illness of Parkinson's Disease in a Large Healthcare PlanHeaton, A. H. / Martin, S. L. / Littlefield, R. S. et al. | 2000
- 57
-
CAN2: Shorter Hospital Length of Stay for Coronary Angioplasty Patients Who Receive Abciximab Versus Eptifibatide or TirofibanLage, M. J. / Barber, B. L. / Scherer, J. / McCollam, P. et al. | 2000
- 58
-
CEB2: Cost-Effectiveness of Meningococcal Vaccine in the UKBrown, R. E. / Sorensen, S. / Batista, C. / Nuijten, M. et al. | 2000
- 58
-
CAN4: Is Prior Community Antibiotic Treatment of Patients Hospitalised with Lower Respiratory Tract Infection Associated with Reduced In-Hospital Mortality and Length of Stay?Steinke, D. / Donnan, P. / MacDonald, T. / Davey, P. et al. | 2000
- 58
-
CEB1: Pharmacogenomics: Evaluating the Economic ImpactVeenstra, D. L. / Higashi, M. K. et al. | 2000
- 59
-
DUC1: Drug Utilization of Cisapride and Contraindicated Drugs in a US Managed Care PopulationGuo, J. J. / Jones, J. K. / Fife, D. / Curkendall, S. / Goehring, E. / She, D. et al. | 2000
- 59
-
CEB3: Cost-Effectiveness of Prevention of Coronary Heart Disease (CHD) with Simvastatin in PolandKuzniar, J. / Orlewska, E. / Hermanowski, T. / Romandzuk, W. / Splawinski, J. et al. | 2000
- 59
-
CEB4: The Cost-Effectiveness of Fixed-Dose Combination of Diclofenac and Misoprostol in Prevention of NSAID-Induced Ulcers in Rheumatoid Arthritis Patients in PolandOrlewska, E. et al. | 2000
- 60
-
DUC2: Insurance Claims Costs for Overactive Bladder in AdultsZhou, Z. / Jensen, G. A. et al. | 2000
- 60
-
DUC3: Smoking Cessation Success Rates with Drug Therapy in a Sample of Medicaid PatientsFincham, J. E. / Braman, K. S. / McNees, G. E. et al. | 2000
- 61
-
MI2: The Number Needed to Treat Approach: Evaluating the Clinical Relevance of Fexofenadine in Seasonal Allergic RhinitisCrawford, B. / Marquis, P. / Offord, S. et al. | 2000
- 61
-
DUC4: High Users of beta~2-Agonists: Are Medicaid Recipients Being Treated According to National Asthma Guidelines?Reddy, P. / Kelly, E. / Kophazi, M. / Geary, E. / Markelon, J. / Welter, K. et al. | 2000
- 61
-
MI1: Identifying Factors Associated with High and Low Cost Asthmatics: Opportunities for Disease Management Using Automatic Interaction DetectionBoscarino, J. A. / Zhao, Z. / Andrews, K. W. / Sokol, M. C. / Yao, J. / McGuigan, K. A. / Gutierrez, B. / Refowitz, R. et al. | 2000
- 62
-
MI3: Reliability and Validity of International Prostate Symptome Score (I-PSS) for Early Assessment of Symptoms in the Treatment of Benign Prostate Hyperplasia (BPH)Singh, A. / Ashraf, T. / Verlinden, M. H. et al. | 2000
- 62
-
MI4: A Framework for Cost-Effectiveness Analysis from Clinical Trial DataO'Hagan, A. / Stevens, J. W. et al. | 2000
- 63
-
S3: Statistical Method for Modeling Dual Selection Bias: Woodwork Effect and Drug Selection Bias Among Multiple AlternativesShi, L. / McCombs, J. S. et al. | 2000
- 63
-
S2: Use of Estrogen Replacement Therapy in Maryland Medicaid FemalesHuang, X. / Weiss, S. R. / Zuckerman, I. H. / Hsu, V. D. et al. | 2000
- 63
-
S1: Impact of Community-Acquired Pneumonia Treatment Guidelines on Length of Stay and CostMerchant, S. V. / Mullins, C. D. / Cooke, C. E. et al. | 2000
- 64
-
BT2: Direct Costs of Obesity in PortugalPereira, J. / Mateus, C. / Amaral, M. J. et al. | 2000
- 64
-
S4: Methods for Comparing Areas Under Receiver Operating Characteristic Curves: Application in Screening Accuracy for DepressionShaw, J. W. / Treglia, M. / Motheral, B. / Coons, S. J. et al. | 2000
- 64
-
BT1: Postoperative Pain Severity After Abdominal or Orthopedic Surgery: Interim ResultsStrassels, S. / Chen, C. / Carr, D. / McDonagh, M. / Gouveia, W. / Wurm, H. et al. | 2000
- 65
-
BT4: Cost-Effectiveness of High Versus Low Dose Angiotensin Converting Enzyme Inhibitors (ACEIs) in the Treatment of Chronic Heart Failure (CHF): An Economic Analysis of the US Assessment of Treatment with Lisinopril and Survival (ATLAS) TrialSchwartz, J. S. / Wang, Y. / Cleland, J. et al. | 2000
- 65
-
BT3: The Comparative Economic Value of Raltitrexed and 5-FU Plus LeucovorinSimons, W. R. / Grace, E. M. et al. | 2000
- 66
-
CEB6: The IMportance of Comparable Patient Populations in Cost-Effectiveness Analyses: Tolterodine Versus Oxybutinin XL for Treating Overactive BladderSchonfeld, W. H. / Sheriff, S. K. / Levaux, H. P. / Williamson, T. E. et al. | 2000
- 66
-
CEB7: Socioeconomic Efficiency of the Adjuvant Treatment with Acamprostate in Maintaining Abstinenance in Alcohol Dependent PatientsKilburg, A. / Daniel, D. / Pfeil, T. / Kirchoff, D. / Rychilk, R. et al. | 2000
- 67
-
PCD1: Incorporating Both Diastolic and Systolic Pressures in a Model of the Benefits of Achieving Hypertension Treatment TargetsHuse, D. M. / Russell, M. W. / Usry, C. A. / Hartz, S. C. et al. | 2000
- 67
-
CEB8: A Decision Analytic Model Measuring the Cost-Effectiveness of Highly Active Antiretroviral Therapy (HAART) in HIV + Patients with High Versus Low Baseline Viral Load: An Indinavir Plus Lamivudine and Zidovudine ExampleRisebrough, N. A. / Oh, P. / Rachlis, A. / McMurchy, D. / Bast, M. / Doswell, M. et al. | 2000
- 68
-
PCD2: Assessing the Burden of Illness in Elderly Versus Younger Acute Coronary Syndrome PatientsEisenstein, E. L. / Peterson, E. D. / Shaw, L. K. / Hasselblad, V. / Nelson, C. L. / Hakim, Z. / Mark, D. B. et al. | 2000
- 68
-
PCD3: Incidence, Utilization of Health Care and Costs of StrokeWilson, L. / Le, K. / Nguyen, C. / Tam, A. / Le, S. et al. | 2000
- 68
-
PCD4: The Impact of Secondary Events on the Cost of Acute Myocardial InfarctionO'Brien, J. / Pierce, D. / Caro, J. et al. | 2000
- 69
-
PCD6: Cost Analysis of Antihypertensive Drug Use in TurkeySapci, H. / Bozkurt, E. / Durlu, T. / Kandilci, B. / Ozsogut, B. / Demirdamar, R. / Akalin, K. / Mutlugil, A. et al. | 2000
- 69
-
PCD5: Costs of Left Ventricular Assist Device Versus Positive Inotropic Therapy as a Bridge to Heart TransplantStanek, E. J. / Loh, E. et al. | 2000
- 69
-
PCD7: Socioeconomic Evaluation of Cilostazol for the Secondary Prevention of Cerebral Infarction in JapanKobayashi, M. / Gotah, F. et al. | 2000
- 70
-
PCD10: Impact of New Statin Doses on Market SegmentationMiller, J. D. / Russell, M. W. / Huse, D. M. / Hartz, S. C. et al. | 2000
- 70
-
PCD8: A Model Comparing Nitroglycerin Formulations for Acute Angina Episodes: Assessing the Economic IssuesBell, C. F. / Semroc, G. N. / Stephens, J. M. / Klingman, D. / Dever, M. T. et al. | 2000
- 70
-
PCD9: Cost-Effectiveness of Ramipril in Hypertensive Patients with Nephropathy in GermanySchadlich, P. K. / Brecht, J. G. / Huppertz, E. et al. | 2000
- 71
-
PCD12: Spironolactone in Heart Failure: Life and Cost Saving Treatment in PolandKuzniar, J. / Orlewska, E. / Splawinski, J. et al. | 2000
- 71
-
PCD13: Cost-Effectiveness Analysis of Enalapril in the Management of CHF in PolandOrlewska, E. / Kuzniar, J. / Romanczuk, W. / Splawinski, J. et al. | 2000
- 71
-
PCD11: The Cost-Effectiveness Analysis as a Substantiation of Diagnostic and Treatment of Early Stage of Heart FailureGorokhova, S. G. / Vorobiev, P. A. et al. | 2000
- 72
-
PCD14: Treatment Cost of Side Effects of Antiarrhythmic Drugs in the USABhattacharyya, S. K. / Morrato, E. H. et al. | 2000
- 72
-
PCD15: How Meaningful Are the Coronary Benefits of Selective Estrogen Receptor Modulators?Russell, M. W. / Huse, D. M. / Miller, J. D. / Hartz, S. C. et al. | 2000
- 73
-
PCD16: Cost-Effectiveness of Tirofiban Plus Heparin as Compared with Heparin Only in Treating Unstable AnginaShi, L. / Hay, J. et al. | 2000
- 73
-
PCD18: The Perceptual Effectiveness Index: A New Approach for Evaluating Outcomes of Anti-Hypertensive TherapyLeidy, N. K. / Flynn, J. / Zyczynski, T. M. et al. | 2000
- 74
-
PCD21: Two-Year Medication Compliance in Patients with Acute Myocardial InfarctionPlante, M. / Gupta, A. / Bruckman, D. / Mehta, R. / Eagle, K. et al. | 2000
- 74
-
PCD19: Relationship Between Daily Dose Frequency and Adherence to Antihypertensive Pharmacotherapy: Update of a Meta-AnalysisIskedjian, M. / Einarson, T. R. et al. | 2000
- 75
-
PCD23: Unadjusted Inpatient Costs and Mortality for Four Cerebrovascular Events for Patients Treated at Community Teaching and Nonteaching HospitalsReed, S. D. / Jarvik, J. G. / Meyer, K. E. et al. | 2000
- 75
-
PCD22: The Effect of Nationality on Health-Related Quality of Life in the Gusto-I Angiographic TrialCoyne, K. / Hill, M. / Allen, J. / Kim, M. / Chandra, N. / Ross, A. et al. | 2000
- 76
-
PCD26: A Closer Look at Hypertension Practice Patterns and Medication ComplianceGuico-Pabia, C. J. / Campbell, R. F. / Dedeker, K. / Sheffeld, R. / Moravec, R. / Wertheimer, A. L. et al. | 2000
- 77
-
PMH1: Recent Trends in the Cost of Care for Patients with SchizophreniaJohnstone, B. M. / Loosbrock, D. L. / Stockwell Morris, L. / Gibson, J. P. / Barber, B. L. / Lichtenstein, M. / Henderson, S. / Dulisse, B. K. et al. | 2000
- 77
-
PMH2: Estimated Costs of Treatment for Bipolar Affective Disorder in a Large Employer DatabaseJohnstone, B. M. / Loosbrock, D. L. / Stockwell Morris, L. / Gibson, J. P. / Barber, B. L. / Lichtenstein, M. / Henderson, S. / Dulisse, B. K. et al. | 2000
- 78
-
PMH4: Antipsychotic Medication Treatment Patterns and Associated Cost of Care of Patients with SchizophreniaLoosbrock, D. L. / Johnstone, B. M. / Stockwell Morris, L. / Gibson, P. J. / Barber, B. L. / Lichtenstein, M. S. / Henderson, S. C. / Dulisse, B. K. et al. | 2000
- 79
-
PMH6: Pharmacoeconomic Analyses of Depot Neuroleptic Treatment in Natural SettingGurovich, I. / Kobina, S. / Lyubov, E. / Litvischenko, Y. / Shmukler, A. et al. | 2000
- 79
-
PMH7: Cost-Effectiveness of Atypical Antipsychotics in Chronic SchizophreniaKarki, S. D. / Bellnier, T. J. / Hager, E. P. et al. | 2000
- 79
-
PMH5: The Effect of Rivastigmine on the Direct and Indirect Costs of Alzheimer's DiseaseBrooks, E. / Deal, L. et al. | 2000
- 80
-
PMH8: Cost-Effectiveness of Stratified Care in the Management of MigraineRapoport, A. / Lipton, R. B. / Williams, P. / Sawyer, J. et al. | 2000
- 80
-
PMH9: A Managed Care Validation Program for a Pharmacoeconomic Model of Major DepressionCasciano, J. / Arikian, S. / Doyle, J. J. / Casciano, R. et al. | 2000
- 80
-
PMH10: A Model to Perform Economic Evaluations of Interventions for Acute Muscular Low Back PainNeighbors, D. / Earnshaw, S. R. / Bell, L. / Bhattacharyya, S. K. et al. | 2000
- 81
-
PMH12: The Efficiency of Drug Treatment in First Episode Schizophrenia: Treatment Guidelines in the UKDavies, L. M. / Lewis, S. et al. | 2000
- 81
-
PMH11: Treatment Guidelines Compared to Clinical Practice for Acute Muscular Low Back PainEarnshaw, S. R. / Neighbors, D. / Bell, L. / Bhattacharyya, S. K. et al. | 2000
- 82
-
PMH13: Withdrawn| 2000
- 82
-
PMH14: Use of Olanzapine and Risperidone at Baseline in a Prospective Study of the Course of Treatment for SchizophreniaJohnstone, B. M. / Dulisse, B. K. / Loosbrock, D. L. / Gibson, P. J. et al. | 2000
- 82
-
PMH15: Utilization of Antipsychotic Medications in the Treatment of Schizophrenia in a Managed Care PopulationNichol, M. B. / Harada, A. S. M. / Jones, J. P. / McCombs, J. S. / Grogg, A. / Gilderman, A. / Vaccaro, J. et al. | 2000
- 83
-
PMH16: Use of Atypical Antipsychotic Medications in a Veterans PopulationHudson, T. / Feng, W. / Owen, R. / Austen, M. et al. | 2000
- 83
-
PMH17: Bipolar Disorder Drug Use Patterns and Compliance in Medi-Cal PopulationLi, J. / McCombs, J. / Stimmel, G. et al. | 2000
- 83
-
PMH18: Use of Nonbarbiturate Sedative/Hypnotic Agents in an Ambulatory PopulationHornquist, M. / Carlson, A. / Morris, L. et al. | 2000
- 84
-
PMH20: Medical Resources Consumption by Patients with Chronic and Breathrough PainNoe, L. / Peeples, P. et al. | 2000
- 84
-
PMH19: Antipsychotic Drug Use Patterns and the Cost of Treating Schizophrenia: Data from the Medicaid Programs of Alabama, Georgia, Kentucky, and MichiganLyu, R. R. / McCombs, J. S. / Johnstone, B. M. / Muse, D. N. et al. | 2000
- 85
-
PMH21: Community Pharmacist Assessment of the Quality of Life of Treated Ambulatory Depressed PatientsTaylor, A. T. / Longe, R. L. / Spruill, W. J. / Wade, W. E. / Wagner, P. J. et al. | 2000
- 85
-
PMH23: How Much Change in Quality of Life and Symptom Scores Represents a Detectable Difference for Schizophrenia Patients?Cramer, J. A. / Rosenheck, R. et al. | 2000
- 85
-
PMH22: Can the Brief "QOLWM" Discriminate Among Migraineurs in the Community?Cramer, J. A. / Silberstein, S. / Winner, P. / Chmiel, J. / Noble, K. et al. | 2000
- 86
-
PMH24: Translations of the Migraine Specific Quality of Life Questionnaire (MSQ): A Psychometric Comparison Between the English, Finnish, Dutch, Hungarian, and Spanish TranslationsGrossman, P. R. / Black, L. K. / Kwong, J. et al. | 2000
- 86
-
PMH25: The Impact of Schizophrenia on Health-Related Quality of Life (HRQL) for Patients Admitted to Psychiatric Units of General Acute Care HospitalsDurkin, M. B. / Edell, W. S. / Mody, S. H. / Adams, B. E. / Repp, E. A. et al. | 2000
- 87
-
PMH28: Quality of Life Differences Between Patients with Episodic and Transformed MigraineMeletiche, D. M. / Lofland, J. H. / Young, W. B. / Hopkins, M. M. et al. | 2000
- 87
-
PMH27: The Impact of Depression on Health-Related Quality of Life (HRQL)Mody, S. H. / Edell, W. S. / Durkin, M. B. / Adams, B. E. / Repp, E. A. et al. | 2000
- 88
-
PMH31: Treatment of Childhood Depression in a Managed Care PopulationMcLaughlin, T. / Yazdani, C. / Hansen, J. / Margraf, T. et al. | 2000
- 88
-
PMH29: The Impact of an Over-The-Counter Migraine Medication on Patient Quality of LifeBurk, C. / Nicho, M. B. / Wu, Q. / Gilderman, A. / Salas, J. et al. | 2000
- 88
-
PMH30: Modeling Length of Prescription Therapy for Depression PatientsBillingsley, J.-K. / Nichols, J. L. et al. | 2000
- 89
-
PMH32: Quantifying the Economic Impact of Potential Drug Interactions in the Treatment of DepressionBourne, M. J. / Prescott, J. D. / Baumann, J. A. / Mayo, K. W. / Bailey, K. L. et al. | 2000
- 89
-
PMH33: Neuroleptic Drug Exposure and Tardive Dyskinesia: A Records-Based Case-Control StudyMarshall, D. L. / Hazlet, T. K. / Gardner, J. S. / Blough, D. K. et al. | 2000
- 90
-
PMH35: Economic Outcomes with Newer Antidepressants for the Treatment of Depression in a Commercially-Insured PopulationMukherjee, R. / Lian, J. / Hines, P. / Dezii, C. / Chen, S. / Scull, R. / Alter, C. et al. | 2000
- 90
-
PMH34: Characterization and Assessment of Depression in a Chronic Non-Malignant Pain Population Using Two Different Methodologies in a Claims DatabaseMody, S. H. / Hsu, A. Y. / Dodd, S. L. et al. | 2000
- 90
-
PMH36: Conformance with Antipsychotic Drug Therapy Guidelines for Treating Schizophrenia in the California Medicaid (Medi-Cal) ProgramLuo, M. / McCombs, J. S. / Shi, L. / Stimmell, G. L. et al. | 2000
- 91
-
PMH38: Response to Nefazodone, Cbasp, and Combined Therapy: Implications for Chronic Depression Severity, Functional Status and Economic OutcomesCrown, W. H. / Berndt, E. / Finkelstein, S. / Russell, J. / Ling, D. / White, A. / Koran, L. / Dunner, D. / Kocsis, J. / Kornstein, S. et al. | 2000
- 91
-
PMH37: Evaluating Healthcare Resource Utilization in a Population of Migraine Patients Using Sumatriptan and Non-Sumatriptan PharmaceuticalsJoish, V. N. / Cady, P. S. / Culbertson, V. L. / Delate, T. et al. | 2000
- 92
-
PMH41: Patterns of Antidepressant Use and Concomitant Psychotherapeutic AgentsFulop, G. / Bona, J. R. / Brookler, R. / Nemeroff, C. B. et al. | 2000
- 92
-
PMH39: Health Care Burden and Cost of Parkinson's DiseaseWilson, L. / Huang, J. / Doshi, D. et al. | 2000
- 92
-
PMH40: Access to New Medications to Treat SchizophreniaMark, T. / Dirani, R. / Russo, P. et al. | 2000
- 93
-
POS1: The Burden of Osteoporosis to the State of Florida: Projections for 2000-2010Burge, R. T. / Worley, D. et al. | 2000
- 93
-
PMH42: The Impact of Adding SSRI Antidepressants to the Medicaid Formulary in CaliforniaMcCombs, J. S. / Shi, L. / Stimmel, G. et al. | 2000
- 94
-
POS2: Interest of the Simple Calculated Osteoporosis Risk Estimatinon (SCORE) Tool for a More Rational Use of Bone DensitometryBenSedrine, W. / Devogelaer, J. P. / Kaufman, J. M. / Goemaere, S. / Depresseux, G. / Bruyere, O. / Reginster, J. Y. et al. | 2000
- 94
-
POS3: The Simple Calculated Osteoporosis Risk Estimation (SCORE) Does Not Allow Identification of Belgian Women with a High Risk of OsteoporosisBenSedrine, W. / Devogelaer, J. P. / Kaufman, J. M. / Goemaere, S. / Depresseux, G. / Bruyere, O. / Reginster, J. Y. et al. | 2000
- 95
-
POS5: Prevalence of Pharmacotherapy for the Treatment and Prevention of Osteoporosis in a Managed Care EnvironmentHall, J. / Nelson, M. et al. | 2000
- 95
-
POS4: Cost-Effectiveness of Screening for Osteoporosis in Elderly WomenDu, H. V. / Hay, J. et al. | 2000
- 96
-
PAR3: Reduced Utilization of Antiulcerant Drugs with Celecoxib: Findings of the Painless TrialCastaldo, R. S. / Luke, D. R. / Grisanti, M. W. / Kalmuk, E. / Palazzo, R. G. / LaDuca, R. L. et al. | 2000
- 96
-
PAR2: Pharmacoeconomical Analysis of Non-Steroid Anti-Inflammatory Drugs in RheumatologyNasonova, V. A. / Vorobjov, P. A. / Tsvetkova, E. S. / Avksentieva, M. V. et al. | 2000
- 97
-
PAR5: Comparing the Health Related Quality of Life Outcomes of Treatment for Early Rheumatoid ArthritisBury-Maynard, D. / Kosinski, M. / Wanke, L. A. / Buatti, M. C. et al. | 2000
- 97
-
PAR4: NSAID Utilization Among Commercially Insured Members in a Managed Care EnvironmentHall, J. / Clouse, J. et al. | 2000
- 97
-
PAR6: Quality of Life Measurements as Predictors of Change in Therapy in Patients with Musculoskeletal DisordersYazdani, C. / Cox, E. R. / Castro, W. L. et al. | 2000
- 98
-
PMW1: The Need for a Quality-of-Life Instrument for Erectile Dysfunction: A Systematic Review of the LiteratureLenderking, W. R. / Sweeney, S. L. / Pashos, C. L. / Flanders, S. C. et al. | 2000
- 98
-
PAR7: The Longterm Safety and Effectiveness of Cyclosporine in Patients with Severe Rheumatoid Arthritis (RA)Marra, C. A. / Guh, D. / Fisher, J. H. / Chalmers, A. / Esdaile, J. / Anis, A. H. et al. | 2000
- 98
-
PMW2: Does Testosterone Affect Health-Related Quality of Life in Healthy, Elderly Males?- A Pilot StudyReddy, P. / White, C. M. / Dunn, A. B. / Moyna, N. M. / Thompson, P. D. et al. | 2000
- 99
-
PMW4: Measurement Properties of Quality of Life Instruments in Erectile Dysfunction (ED): A Review of Published ResultsEmery, M. P. / Kunle, A. / Marquis, P. / Sagnier, P. P. / Kubin, M. et al. | 2000
- 99
-
PMW3: Prescription Drug Use During Pregnancy: A Claims AnalysisZenk, H. A. / Carlson, A. et al. | 2000
- 100
-
PMW6: Matching VA Urologists' Preferences in the Management of Benign Prostatic Hyperplasia with Clinical Practice GuidelinesFernandes, A. W. / Amonkar, M. M. / Madhavan, S. / Nseyo, U. O. et al. | 2000
- 100
-
PMW5: A Pharmacoeconomic Evaluation of Hormone Replacement Therapy in the United Kingdom and BelgiumDoyle, J. J. / Arikian, S. / Casciano, J. / Casciano, R. / Baleeva, J. / Gonzalez, M. A. et al. | 2000
- 100
-
PMT1: The Value of Observational Datasets in the Economic Evaluation of Pharmaceuticals: UK ObservationsTolley, K. / Pang, F. / Brown, M. et al. | 2000
- 101
-
PMT2: Reliability of Prescription Claims Data for Health Care ResearchThomas, J. / Hutchins, D. S. / Fehr, A. F. / Mitrany, D. et al. | 2000
- 102
-
PMT4: Methodological Issues in Estimating Disease Progression: Is Markov Model the Best Method?Shih, Y. C. / Ke, X. T. et al. | 2000
- 102
-
PMT5: Development of Multi-Language Patient Outcome AssessmentsRentz, A. M. / Trudeau, E. / Schmier, J. K. / Dubois, D. / Jones, R. / Marquis, P. / Willian, M. K. / Revicki, D. A. et al. | 2000
- 103
-
PMT7: The French Health Utilities Index Mark 3Le Gales, C. / Buron, C. / Costet, N. / Rosman, S. / Slama, G. et al. | 2000
- 103
-
PMT8: Development of a New Scoring of the Women's Health Questionnarie (WHQ)Girod, I. / Keininger, D. / de la Loge, C. / Hunter, M. et al. | 2000
- 104
-
PMT9: Assessing the Cost-Effectiveness Ratio of a New Anti-Platelet Agent: Methodologic IssuesLevy, E. / Gabriel, S. / Dinet, J. / Carita, P. et al. | 2000
- 104
-
PMT10: Modelling Issues: First Episode SchizophreniaDavies, L. M. / Lewis, S. et al. | 2000
- 105
-
PMT13: Transfering the Results from Economic Evaluations: The Use of Baxiliximab in Transplant PatientsLee, K. M. / Coyle, D. / Baladi, J. F. et al. | 2000
- 106
-
PMT16: Estimation of Annual Cardiovascular Risk in PilotsMilne, R. J. et al. | 2000
- 106
-
PMT15: Validation of Framingham Regression Equations for Local UseMilne, R. J. et al. | 2000
- 106
-
PMT14: Improving the Evidence Base of Economic AnalysesCoyle, D. / Lee, K. M. et al. | 2000
- 107
-
PMT19: Non-Randomized Studies Comparing Olanzapine and Risperidone: Baseline Similarities and DifferencesGibson, P. J. / Loosbrock, D. L. et al. | 2000
- 107
-
PMT18: Bias Arising from Missing Data in a Retrospective Study of the Outcomes of Intra-Abdominal InfectionsDavey, P. / Libby, G. / Hunter, K. / Broomhall, J. / Kosteridis, D. / Steinke, D. / Yin, D. et al. | 2000
- 107
-
PMT17: Dealing with Skewed Data: An Example Using Asthma-Related Costs of Medicaid ClientsRascati, K. L. / Smith, M. J. et al. | 2000
- 108
-
PMT22: Treatment Satisfaction in Outcomes Research: An Overview of Study MeasuresWang, A. Y. / Graham, L. A. / Copley-Merriman, C. et al. | 2000
- 108
-
PMT21: Deriving Health Utilities from Efficacy Outcome Scales in Alzheimer's Disease (AD)Lanctot, K. L. / Oh, P. I. / Risebrough, N. / Mazzotta, P. et al. | 2000
- 108
-
PMT20: The Use of Economic Analyses in Practice Guideline DevelopmentWallace, J. F. / Ofman, J. J. / Hohlbauch, A. A. / Lewensztain, L. S. / Richards, M. S. / Henning, J. M. / Weingarten, S. R. et al. | 2000
- 109
-
PMT23: Monte-Carlo Simulation as an Alternative Technique in Addressing the Unit Cost Variability IssueTran, G. / McKenna, M. / Kennedy, L. / Pang, F. et al. | 2000
- 109
-
PMT24: "Camouflaged Sampling" Using BC Ministry of Health Data: A Method of Recruiting Subjects While Preserving Data PrivacyMaclure, M. / Lynd, L. D. / Warren, L. D. / Pare, P. D. / Anis, A. H. et al. | 2000
- 110
-
PMT26: Fieller's Interval, Its Extensions and Their Applications in Cost-Effectiveness AnalysesJiang, G. J. / Williams, G. R. / Wu, J. et al. | 2000
- 110
-
PMT25: Comparative Econometric Models of Medical CostsWu, Q. / Hay, J. W. et al. | 2000
- 111
-
PMT29: The Influence of Statistical Errors on the Cost-Effectiveness of Treatments Following a Phase-III Clinical TrialKamae, I. / Yanagisawa, S. et al. | 2000
- 111
-
PMT30: Preference Based Index from the SF-12Sengupta, N. / Nichol, M. B. / Globe, D. et al. | 2000
- 112
-
PMT31: An Assessment of Cost-Utility of Patients from SF-36 Scores Using the Beaver Dam Health Outcomes Study MethodNadesan, B. / Cady, P. / Culbertson, V. et al. | 2000
- 112
-
PMT32: Utility Estimation Using the EQ-5D: Expert Panel Data and Alternative Methods of SynthesisSmith, D. / Davies, L. / Manca, A. / Kind, P. et al. | 2000
- 113
-
PMT33: Linguistic Validation of the Vascular Quality of Life Questionnaire (VASCUQOL) in 8 LanguagesConway, K. / Uzun, V. / Girod, I. / Morgan, M. / Koch, P. et al. | 2000
- 113
-
PMT35: Valuing Non-Workplace Productivity Lost in Migraineurs: Human Capital Approach and Replacement Cost MethodKim, S. S. / Lofland, J. H. et al. | 2000
- 113
-
PMT34: Assessing Physician Practice Profitability Using an Activity Based Costing ModelStephens, J. M. / Bell, C. F. / Klingman, D. et al. | 2000
- 114
-
PMT37: Benefits of Early Modeling in Drug DiscoveryStevenson, M. / Bryant-Comstock, L. / Brennan, A. et al. | 2000
- 115
-
PWP2: A Methodology to Measure Productivity of Health Outcomes GroupsSesti, A. M. / Abright, J. / McLaughlin-Miley, C. / Copley-Merriman, C. et al. | 2000
- 115
-
PWP3: Consumer Preferences for Dental Anesthesia: Putting Your Money Where Your Mouth IsMatthews, D. / Rocchi, A. / Garni, A. et al. | 2000
- 116
-
PWP4: A Willingness-to-Pay Assessment of Two Treatments for ObesityTrakas, K. / Oh, P. I. / Shear, N. H. et al. | 2000
- 116
-
PWP5: Work Productivity Effects of Diabetes: Implications for Research and PolicyLavigne, J. E. et al. | 2000
- 116
-
PWP6: A Preliminary Study of Provision of Pharmaceutical Care in Community Pharmacy in Singapore: Cost Analysis & Patient Willingness to PayLi, S. C. / Chan, S. Y. / How, P. P. et al. | 2000
- 117
-
PHV2: The Burden of Respiratory Synctial Virus (RSV) Hospitalizations in the USHoward, T. S. / Stang, P. E. et al. | 2000
- 117
-
PHV1: Utilization of Intensive Care and Hospital Days and Outcome in Patients with Severe Sepsis: The Select II RegistryFormica, C. A. / Drabinski, A. / Kim, S. / Williams, G. R. et al. | 2000
- 117
-
PHV3: Modelling a Cost-of-Illness Study to Evaluate the Burden of Influenza in ItalyAimola, A. / Gianfrate, F. et al. | 2000
- 118
-
PHV5: Effectiveness and Costs of Antibiotics in the Ambulatory Treatment of Respiratory Tract InfectionsLaurier, C. / Lachaine, J. / Manzi, P. et al. | 2000
- 119
-
PHV7: Managing Pneumocystosis: The Cost of Hospitalization in the USO'Brien, J. / Pierce, D. / Caro, J. et al. | 2000
- 119
-
PHV8: Uncomplicated Acute Pyelonephritis in Adult Women: Inpatient Versus Outpatient Therapy - Economic ComparisonTibi-Levy, Y. / Elkharrat, D. / de Pouvourville, G. et al. | 2000
- 119
-
PHV6: Economic Evaluation of a Safety Device for Subcutaneous Injections of Low Molecular Weight Heparin (LMWH)Durand-Zaleski, I. / Gabriel, S. / Dinet, J. et al. | 2000
- 120
-
PHV9: Cost of Treating Hispanic Patients with AIDS in US HospitalsO'Brien, J. / Pierce, D. / Jackson-Kelley, H. / Caro, J. et al. | 2000
- 120
-
PHV11: Cost-Minimization Analysis of Azithromycin IV/PO Versus Cefuroxime IV/PO +/-Erythromycin IV/PO for Community-Acquired PneumoniaWong, A. H. / Phillips, E. / Tailor, S. A. / Cornish, W. / Shear, N. H. / Lavoie, F. et al. | 2000
- 120
-
PHV10: A Preliminary Study: The Pharmacoeconomic Profile of Antibiotic Use in TurkeySapci, H. / Bozkurt, E. / Durlu, T. / Kandilci, B. / Ozsogut, B. / Demirdamar, R. et al. | 2000
- 121
-
PHV13: Cost Analysis of Ceftriaxone Versus Ceftriaxone Plus Macrolide Treatment for Patients Hospitalized with Community-Acquired Pneumonia (CAP)Truong, K. / Kucukarslan, S. / Ailani, R. / Wright, D. / DiGiovine, B. et al. | 2000
- 121
-
PHV12: Management Strategies for Ribavirin-Induced Hemolytic Anemia in the Treatment of Hepatitis C: Clinical and Economic ImplicationsDevine, E. B. / Kowdley, K. V. / Sullivan, S. D. / Veenstra, D. L. et al. | 2000
- 121
-
PHV14: A Multinational Pharmacoeconomic Evaluation of the Seven-Valent Pneumococcal Conjugate VaccineArikian, S. / Ciuryla, V. / Doyle, J. J. / Casciano, J. / Casciano, R. / Hvidsten, K. et al. | 2000
- 122
-
PHV15: Clinical and Economic Benefits of the Pneumococcal Conjugate Vaccine in ChildrenOster, G. / Weycker, D. / Ciuryla, V. / Richardson, E. / Thompson, D. et al. | 2000
- 122
-
PHV17: Preliminary Assessment of the Economic Value of Adult Pertussis Booster VaccinationBotteman, M. F. / Pashos, C. L. / Staginnus, U. et al. | 2000
- 122
-
PHV16: An Unusual Economic Evaluation of Efavirenz Compared to IndinavirMigliaccio-Walle, K. / Raggio, G. / O'Brien, J. / Caro, J. et al. | 2000
- 123
-
PHV18: Safety-Net Hospital Perspective: Cost-Effectiveness of Treatment for Hepatitis CSinger, M. E. et al. | 2000
- 123
-
PHV19: Impact of Antibiotic Choice on Costs, Outpatient Visits, and 28-Day Outcomes for Community-Acquired Pneumonia PatientsBell, T. J. / Mauskopf, J. A. / Gallagher, K. M. / L'Italien, G. J. / Anton, S. et al. | 2000
- 124
-
PHV22: Utilization and Cost-Effectiveness of Antimicrobials in Community-Acquired PneumoniaKarpov, O. / Zaytsev, A. et al. | 2000
- 124
-
PHV20: Cost-Effectiveness Analysis of Lamivudine Treatment in Chronic Hepatitis BYeh, Y. C. / Biddle, A. K. / Hartzema, A. G. et al. | 2000
- 124
-
PHV21: Preliminary Assessment of the Economic Value of Pertussis Booster Vaccination of Hospital StaffBotteman, M. F. / Pashos, C. L. / Staginnus, U. et al. | 2000
- 125
-
PHV25: Quality of Life of Adult Patients Treated for a Respiratory Tract InfectionLachaine, J. / Laurier, C. / Manzi, P. et al. | 2000
- 125
-
PHV23: Patient Adherence with Multi-Drug HIV Therapy: Variations in Adherence and Correlation with HIV RNA LevelsFarmer, K. C. / Rathbun, C. / Clay, P. / Stephens, J. / Bui, T. / Slater, L. et al. | 2000
- 126
-
PHV27: Costs and Outcomes of Treating Febrile Neutropenia in Nine European CountriesFlynn, J. / Elixhauser, A. / Constenla, D. / Baleva, J. / Ciuryla, V. et al. | 2000
- 126
-
PHV26: Effectiveness of Antibiotic Prescribing and Patient Outcomes in a Community Setting: The Australian ExperienceBeilby, J. / Marley, J. / Walker, D. / Chamberlain, N. / Lydick, E. / Hess, G. / Burke, M. et al. | 2000
- 127
-
PHV29: Variability in the Criteria for Early Switch and Early Discharge in Community-Acquired Pneumonia: A Systematic Review of the LiteratureRhew, D. C. / Tu, G. S. / Ofman, J. / Henning, J. M. / Richards, M. S. / Weingarten, S. R. et al. | 2000
- 127
-
PHV30: Costs and Outcomes of a Respiratory Syncytial Virus Prophylaxis Program in a Medicaid Managed Care OrganizationSchaffer, M. / Amaya, M. A. / Vojta, D. et al. | 2000
- 127
-
PHV28: Withdrawn| 2000
- 128
-
PHV31: Withdrawn| 2000
- 129
-
PCN3: Predictors of Cervical Cancer Inpatient Admission Costs by StageBerg, G. D. / Chattopadhyay, S. K. et al. | 2000
- 129
-
PCN2: Withdrawn| 2000
- 130
-
PCN6: Cost-Effectiveness of Genetic Testing in Hereditary Non-Polyposis Colorectal CancerHenderson, L. B. / Scheuner, M. T. / Ofman, J. J. et al. | 2000
- 130
-
PCN7: Cost-Effectiveness of Rituximab in Relapsed, Refractory, Low-Grade Non-Hodgkin's LymphomaCattaneo, M. J. / Nichol, M. B. et al. | 2000
- 131
-
PCN9: Patterns of Epoetin Alpha Utilization in Anemic Cancer PatientsScott, W. G. / Arbuckle, R. B. / McCormick, W. / Sansgiry, S. S. et al. | 2000
- 132
-
PCN10: Psychometric Validity of Quality of Life and Utility Measures in Non-Small Cell Lung Cancer (NSCLC): A Literature ReviewEmery, M. P. / Adesina, K. / Marquis, P. / Van Gool, R. et al. | 2000
- 132
-
PCN12: Racial Differences in the Cost of Treating Early Stage Prostate CancerBrandeis, J. / Pashos, C. L. / Henning, J. M. / Litwin, M. S. et al. | 2000
- 132
-
PCN11: Symptomatic Anemia During Cancer Chemotherapy: rhErythropoietin (rhEPO) and Quality of LifeBonicatto, S. / Giacomi, N. / Ferreras, R. / De la Cruz, J. / Cichetti, G. / Gelemur, M. / Riva, M. / Ivulich, C. / Ferreyra, L. et al. | 2000
- 133
-
PCN13: Colonoscopy Charges in a Managed Care Population: Differences Based on Polypectomy and Malignancy StatusGandhi, S. K. / Mehta, S. S. / McLaughlin, T. / Okamoto, L. / Boyer, J. G. et al. | 2000
- 133
-
PCN14: Effectiveness of Erythropoietin in Cancer PatientsMorris, C. / Halberg, D. L. / McIntyre, W. J. et al. | 2000
- 134
-
PCN15: Cost-Effectiveness of Tamoxifen in Breast Cancer Risk ReductionSengupta, N. / Hay, J. W. et al. | 2000
- 134
-
PCN16: Validity of the Time-Trade Off Technique in Determining Preferences for the Treatment of Prostate CancerWatkins Bruner, D. / Baron, J. et al. | 2000
- 135
-
PDB1: Resource Use and Cost Associated with Micro- and Macrovascular Complications in Patients with Type 2 DiabetesGoertz, A. / Spannheimer, A. / Reitberger, U. / Liebl, A. / Neiss, A. et al. | 2000
- 136
-
PDB4: Cost-Effectiveness of Diabetic Foot Ulcer Treatment with Autologous Platelet ReleasateKantor, J. / Margolis, D. J. et al. | 2000
- 136
-
PDB5: Cost-Effectiveness of Rentinopathy Screening in Pediatric Patients with Type I Diabetes MellitusLi, J. / Hay, J. et al. | 2000
- 136
-
PDB3: The Effects of Age and Complications on the Cost of Managing Members with Type 2 Diabetes MellitusMartinson, M. S. / Liao, E. / Newell, J. A. et al. | 2000
- 137
-
PDB6: Evaluation of Clinical and Demographic Factors Associated with Diabetic Foot Ulcer Treatment CostsWade, S. W. / Kadlubek, P. J. / Fastenau, J. M. / Gause, D. / Thomasson, J. / Goldberg, G. A. et al. | 2000
- 137
-
PDB7: Treatment Costs of Type-2 Diabetes Mellitus Patients with and without Selected Cardiovascular ComorbiditiesBhattacharyya, S. K. / Else, B. A. et al. | 2000
- 138
-
PDB9: Cost of Concomitant Illnesses Among Patients with Hypertension and DiabetesFarquhar, I. V. / Jackson, J. D. / Weir, E. et al. | 2000
- 138
-
PDB8: Health Related Quality of Life (HRQOL) Measures in Type 2 DiabetesChang, J. / Guo, A. / Rodriguez, J. / Chen, Y. / McNulty, P. / Martens, L. et al. | 2000
- 138
-
PDB10: Economic Outcomes of HMG CoA Reductase Inhibitors in a Hypertensive Diabetic Population in a Managed Care OrganizationWhite, T. J. / Juzba, M. / Berenbeim, D. M. / Gilderman, A. M. / Salas, J. C. et al. | 2000
- 139
-
PDB11: Evaluation of a Diabetes Disease Management Program in a Nursing HomeLonge, R. L. / Wagner, P. J. et al. | 2000
- 139
-
PRN1: Overactive Bladder Cost of Illness: Analysis of Medi-Cal ClaimsBailey, K. L. / Torigoe, Y. / Zhou, S. / Mo, L. S. / Flewelling, S. L. et al. | 2000
- 140
-
PRN4: Assessing Quality of Life in Routine Clinical Practice: A Pilot Study in Patients with Renal DiseaseWild, D. / Grove, A. / Keogh, A. / Farina, C. et al. | 2000
- 140
-
PRN2: Cost-Effectiveness of Basiliximab, Daclizumab, and OKT3 as Induction Agents in Kidney TransplantationShin, G. P. / Johnson, N. / Vasquez, E. / Walton, S. et al. | 2000
- 140
-
PRN3: Cost Analysis of "Optimal" US Dialysis Modality UtilizationJust, P. M. / Mendelssohn, D. C. / Mehta, R. L. et al. | 2000
- 141
-
PRN6: Developing a Specific HRQL Instrument for Overactive BladderCoyne, K. / Schmier, J. / Hunt, T. / Corey, R. / Liberman, J. / Revicki, D. et al. | 2000
- 141
-
PRN7: Reliability of Reporting on Coping Strategies and Impact of Overactive BladderStewart, W. F. / Hunt, T. / Payne, C. K. et al. | 2000
- 141
-
PRN5: Quality of Life and Health Care Resource Utilization in Overactive Bladder Patients with Urge IncontinenceRosner, A. J. / Becker, D. L. / Borrie, M. J. / Hobbs, C. / Fedorkow, D. M. / Vallely, J. F. / King, H. J. / Turpie, I. et al. | 2000
- 142
-
PRN8: Medical Care of Overactive Bladder in Elderly Medicare PatientsJensen, G. A. / Zhou, Z. / Torigoe, Y. et al. | 2000
- 142
-
PRN9: The Influence of Pharmaceutical Care Services on the Blood Pressure of Renal Transplant PatientsChisholm, M. A. / Vollenweider, L. J. / Martin, B. C. / Mulloy, L. / Jagadeesan, M. / DiPiro, J. T. et al. | 2000
- 143
-
PRS1: Direct and Indirect Costs of Asthma to an EmployerBirnbaum, H. G. / Greenberg, P. E. / Wanke, L. A. / Atkins, K. et al. | 2000
- 143
-
PRS2: Impact of a Targeted Asthma Intervention Program on Treatment CostsSuh, D. C. / Shin, S. K. / Voytovich, R. M. / Okpara, I. / Zimmerman, A. et al. | 2000
- 143
-
PRS3: Trends in the Use of beta-Agonist Medications in British Columbia: An Analysis of BC Pharmacare DataLynd, L. D. / Raboud, J. / Guh, D. / Pare, P. D. / Anis, A. H. et al. | 2000
- 144
-
PRS6: Classifying Asthma Severity Based on Prescription Drug ClaimsLeahy, M. J. / Klingman, D. / Bell, C. F. et al. | 2000
- 144
-
PRS5: Impact of Inhaled Corticosteroids (Fluticasone Propionate) on Economic Outcomes in a Managed Care EnvironmentOates, V. / Vaziri, B. / Ober, J. / Gothard, L. et al. | 2000
- 145
-
PRS8: Economic Outcomes of Steroid Inhaler Use Patterns in a Managed Care OrganizationWhite, T. J. / Juzba, M. / Berenbeim, D. M. / Gilderman, A. M. / Salas, J. C. et al. | 2000
- 145
-
PRS7: Drivers of Diagnosis of Obstructive Lung Disease, by Stage of SeveritySilberman, C. / Lally, C. / Lydick, E. et al. | 2000
- 146
-
PRS9: Predictors of Hospitalization and Emergency Room Use in a Medicaid Managed Care Asthmatic PopulationDrabinski, A. M. / Schaffer, M. / Chatterton, M. L. et al. | 2000
- 146
-
PRS10: Annual Cost of Treating Asthma in a Managed Care PopulationYazdani, C. / Stanford, R. / McLaughlin, T. / Margraf, T. et al. | 2000
- 146
-
PSG1: Inpatient Utilization of Medical Services Associated with Peripheral Arterial Disease-Related Inpatient Procedures in the Department of DefenseZachry, W. M. / Shepherd, M. D. / Wilson, J. P. et al. | 2000
- 147
-
PSG4: Traumatic Colon Injuries: Difference in Hospital Costs by Type of Surgical RepairO'Brien, J. / Pierce, D. / Jacobs, L. et al. | 2000
- 148
-
PSG5: The Economic Impact of the Use of Perfluoro-N-Octane During Retinal Detachment SurgeryVenkataraman, K. S. / Barnes, J. R. / Scott, I. U. et al. | 2000
- 148
-
PSG6: Cost-Minimization Analysis of Epoetin Alpha in the Community HospitalSantorello, J. G. et al. | 2000
- 149
-
PSG9: Clinical and Economic Outcomes of Coronary Angioplasty Alone or in Combination with Stents in Academic Health Centers: A Retrospective Database AnalysisOinonen, M. J. / Akhras, K. S. / Chen, C. / Matuszewski, K. A. / Vlasses, P. H. et al. | 2000
- 149
-
PSG7: Postoperative Pain Relief, Interference with Activities, and Satisfaction: Preliminary ResultsStrassels, S. / Chen, C. / Carr, D. / McDonagh, M. / Gouveia, W. / Wurm, H. et al. | 2000
- 149
-
PSG8: Long-Term Outcomes and Resource Use Associated with MyomectomySubramanian, S. / Clark, M. A. / Quinn, V. C. et al. | 2000
- 150
-
PSG10: Restenosis and Medical Costs Following Percutaneous Transluminal Coronary Angioplasty (PTCA) with and without StentSen, S. / Khandker, R. / Roth, D. / Thomas, J. et al. | 2000
- 150
-
PSG11: Cost Analysis of Inhaled Agents in Canadian Pediatric HospitalsBussieres, J. F. / Giguere, M. et al. | 2000
- 150
-
PSG12: Hospital Cost Savings from Severity-Adjusted Length of Stay Following Surgery for Intra-Abdominal Infection and Treatment with Piperacillin/Tazobactam or Impipenem/CilastatinBjerke, S. / Mallick, R. / Clark, K. / Wible, M. / Zito, E. / Guttman, R. / Sillup, G. et al. | 2000
- 151
-
PSG14: Cost-Effective Strategies: Assessing Pharmacists Intervention in a Community Hospital Intensive Care UnitDilanchian, P. / Sansgiry, S. S. et al. | 2000
- 152
-
PGD2: Improved Drug Compliance Using Education Affects Medical Utilization and Quality of Life for Peptic Ulcer Disease PatientsAddiego, J. / Berger, J. / McStay, P. / Craig, R. / O'Leary, W. / Slezak, J. / Schwaab, M. / Hasan, E. / Apolinski, L. et al. | 2000
- 152
-
PGD1: Over-the-Counter NSAID Use and GI ToxicityBloom, B. S. / Straus, W. L. / Thomas, J. / Berger, M. I. et al. | 2000
- 152
-
PGD3: Prospective Evaluation of an Information Dissemination Program Incorporating Peer Comparison Feedback in Peptic Ulcer Disease ManagementDennett, S. L. / Thomas, J. / Sen, S. / Bernard, P. G. / Cramer, S. / Schumacher, J. / Lang, J. et al. | 2000
- 153
-
PDH2: Factors Related to Prescription Drug Expenditure Growth: Volume vs. PriceChawla, A. J. / Dubois, R. W. / Neslusan, C. A. / Smith, M. S. / Wade, S. W. et al. | 2000
- 153
-
PGD4: The Clinical and Economic Impact of Competing Management Strategies for Gastroesophageal Reflux Disease (GERD)Ofman, J. / Fennerty, M. B. / Dorn, G. / Fass, R. et al. | 2000
- 153
-
PDH1: Economic Implications for Safety-Net Hospitals: Screening for Hepatitis CSinger, M. E. et al. | 2000
- 154
-
PDH4: Technology Assessment in the US: What Do Payers Understand and What Information Do They Want?Evans, C. / Crawford, B. / Dukes, E. et al. | 2000
- 155
-
PDH7: The Impact of Locus of Control on ComplianceReed, P. / Gourley, G. / Herrier, R. / Gourley, D. et al. | 2000
- 155
-
PDH5: Health Care Expenditure in an HMO Before and After an Exclusive Pharmacy PartnershipPeris, A. / Castiglione, B. / Vanscoy, G. J. et al. | 2000
- 156
-
PDH10: Potential Value for Money of Research: Beta Interferon and the UK-MS StudyDavies, L. / Smith, D. et al. | 2000
- 156
-
PDH8: Subspecialists: Do They Provide Better Quality and More Efficient Care? An Analysis of Outcomes Data from 6 HospitalsWeingarten, S. R. / Lloyd, L. E. / Braunstein, G. D. et al. | 2000
- 156
-
PDH9: Drug and Examination in Relation to the Total Therapy Costs-a Cost Management Dilemma?Schmelzer, A. / Klask, J. / Losch, M. et al. | 2000
- 157
-
PDH11: Evaluation of Cigarette Smokers' Perceptions of Smoking Cessation and the Role of Health Care ProfessionalsDodd, M. A. / Gupchup, G. V. et al. | 2000
- 157
-
PDH12: A Randomized Controlled Multi-Center Study Evaluating the Effect of Pharmaceutical Care on Changes in Quality of LifeMalone, D. C. / Carter, B. L. / Billups, S. J. / Ellis, S. et al. | 2000
- 158
-
PDH14: Compliance and Persistency Benefits Achieved by Utilizing a Once Daily Extended Release Medication vs. a Twice Daily RegimenDezii, C. M. / Kawabata, H. / Tran, M. et al. | 2000
- 158
-
PDH13: Quality of Care Inferences from Multivariate Analysis of Ambulatory DataKroch, E. / Brailer, D. et al. | 2000
- 158
-
PDH15: Withdrawn| 2000
- 159
-
PDH18: Enter the Dragon: Pharmacoeconomics in AsiaPang, F. / Tran, G. et al. | 2000
- 159
-
PDH17: Are the British Government's Healthcare Reforms Targeting Patients' Needs?: Evidence from a Comparison of Two GP Surveys on Musculoskeletal CareDickson, D. J. / Hosie, G. / English, J. / Dickson, A. J. et al. | 2000
- 159
-
PDH16: Identifying Patients with Psychoses in a Medicaid Managed Care Organization with Carved-Out Behavioral Health ServicesBachleda, M. J. / Moxey, E. / Goldfarb, N. / Schaffer, M. et al. | 2000
- 160
-
PDH19: Analysis of the Total Cost and Resources Consumed in Cases of Single and Concurrent Chronic IllnessGaris, R. I. / Farmer, K. C. / Jacobs, E. W. et al. | 2000
- 161
-
PDH22: Modelling the Benefits of Verteporfin Therapy in Macular DegenerationSmith, D. / Fenn, P. / Drummond, M. et al. | 2000
- 161
-
PDH21: Pre-Post and Between Group Differences in Patient Outcomes in a Pharmaceutical Care Intervention ProjectKamath, T. V. / Chaikledkaew, U. / Johnson, K. A. et al. | 2000
- 161
-
PDH20: Content Analysis of Pharmacoeconomic Advertising in Specialty and Primary Care JournalsSullivan, P. W. / Hirsch, J. D. / Nichol, M. B. / Conner, C. / Teratanaut, R. et al. | 2000
- 162
-
PDH25: A Qualitative Assessment of Managed Care Decision-Makers' Views and Use of Pharmacoeconomic InformationGrizzle, A. / Motheral, B. / Garrity, B. / Cox, E. / Armstrong, E. et al. | 2000
- 162
-
PDH23: Relevance of Pharmacoeconomics and Health Outcomes Information to Health Care Decision-Makers in the United StatesCox, E. / Motheral, B. / Griffis, D. et al. | 2000
- 162
-
PDH24: Pharmaceutical Industry Perceptions of the Use of Pharmacoeconomic Data by Health Care OrganizationsArmstrong, E. P. / Abarca, J. / Motheral, B. R. / Grizzle, A. J. et al. | 2000
- 163
-
PDH26: A National Survey of Decision-Makers in Managed Care on Their Views and Use of Pharmacoeconomic InformationMotheral, B. / Grizzle, A. / Armstrong, E. / Cox, E. / Bataoel, J. / Bennett, D. / Shahriar, J. et al. | 2000
- 163
-
PDH27: The Satisfaction and Economic Evaluation of Converting a Traditional Hospital System Using a Unit Dose System, at a Hospital in Barbados, West IndiesGriffith, J. A. / Lai, L. et al. | 2000
- 164
-
PDH28: A Drug Cost Model for a Capitated Patient Population Within an Integrated Health Care SystemPatel, R. P. / Petitta, A. / Andrews, M. J. et al. | 2000
- 164
-
PDH29: Factors Affecting Asthmatic, Diabetic, and Hypertensive Patient Self-Reported Compliance in a Pharmaceutical Care Demonstration ProjectChaikledkaew, U. / Kamath, T. / Johnson, K. A. et al. | 2000
- 164
-
PDH30: Role of HRQL Evaluation in the Drug Regulatory Process: Preliminary Results from a European Regulatory SurveyAcquadro, C. et al. | 2000
- 165
-
PDH31: Health Related Quality of Life and Regulatory Issues: Comparison of US and European InitiativesMarquis, P. / Abetz, L. / Acquadro, C. et al. | 2000
- 165
-
PDH33: Evaluation and Treatment of Short Stature: National Cooperative Growth Study (NCGS) ExperienceBlethen, S. L. et al. | 2000
- 165
-
PDH32: Cost Impact of a Prescription Benefit Change in a Medicare Managed Care PlanBalkrishnan, R. / Byerly, W. G. et al. | 2000